For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Chronic heart failure leads to higher risk of iron deficiency: Patients need testing
+Print Archive
CLINICAL UPDATE
Chronic heart failure leads to higher risk of iron deficiency: Patients need testing
Wednesday 24 April 2019, 01:00 AM

Fatigue is a clinical consequence of iron de ciency in patients with CHF
Treating iron deficiency in heart failure improves patients’ energy, exercise capacity and quality of life, and cuts their risks for hospitalisation and death
Anaemia is a frequent finding in patients with chronic heart failure; it is present in approximately one-third of patients with CHF.1–3 Anaemia in CH
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.